MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on Humana Basic Rx Plan (S5884-116)

levomilnacipran hydrochloride

Covered, with prior authorization required.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$146.50
Patient pays / month, after deductible
$523.20
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 80 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $523.20 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$149.40PA · 30 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$147.13PA · 30 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$150.50PA · 30 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$146.50PA · 30 per 30 days
FETZIMA Kit4$154.16PA · 28 per 28 days

Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5884-116